RecruitingPhase 1NCT03918408

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions

Sponsor

Pacific Clear Vision Institute

Enrollment

300 participants

Start Date

Sep 1, 2019

Study Type

INTERVENTIONAL

Conditions

Bacterial Keratitis Ectasia of Cornea Keratoconus, Unstable

Summary

To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.

Eligibility

Min Age: 12 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution for people with bacterial keratitis, ectasia of cornea, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTPXL-330 Platinum device for crosslinking with Peschke ribofflavin solution

Riboflavin will be used to load the cornea, followed by UV-A crosslinking of the cornea

Locations(1)

Pacific Clear Vision Institute

Eugene, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03918408

Related Trials

Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis

NCT073942571 location

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

NCT0712491012 locations

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

NCT064511721 location